The New England journal of medicine 381 (2019): 1023–1034. doi:10.1056/NEJMoa1905248 info:cnr-pdr/source/autori:Criner G J; Celli B R; Brightling C E; Agusti A; Papi A; Singh D; Sin D D; Vogelmeier C F; Sciurba F C; Bafadhel M; Backer V; Kato M; Ramirez-Venegas A; Wei Y-F; Bjermer L; Shih V H; Jison M; O'Quinn S; Makulova N; Newbold P; Goldman M; Martin U J GALATHEA STUDY INVESTIGATORS;/titolo:Benralizumab for the Prevention of COPD Exacerbations/doi:10.1056%2FNEJMoa1905248/rivista:The New England journal of medicine (Print)/anno:2019/pagina_da:1023/pagina_a:1034/intervallo_pagine:1023–1034/volume:381 Criner, G J, Celli, B R, Brightling, C E, Agusti, A, Papi, A, Singh, D, Sin, D D, Vogelmeier, C F, Sciurba, F C, Bafadhel, M, Backer, V, Kato, M, Ramírez-Venegas, A, Wei, Y-F, Bjermer, L, Shih, V H, Jison, M, O'Quinn, S, Makulova, N, Newbold, P, Goldman, M, Martin, U J, GALATHEA Study Investigators, Bødtger, U & TERRANOVA Study Investigators 2019, ' Benralizumab for the Prevention of COPD Exacerbations ', The New England Journal of Medicine, vol. 381, no. 11, pp. 1023-1034 . https://doi.org/10.1056/NEJMoa1905248 Criner, G J, Celli, B R, Brightling, C E, Agusti, A, Papi, A, Singh, D, Sin, D D, Vogelmeier, C F, Sciurba, F C, Bafadhel, M, Backer, V, Kato, M, Ramírez-venegas, A, Wei, Y, Bjermer, L, Shih, V H, Jison, M, O’quinn, S, Makulova, N, Newbold, P, Goldman, M & Martin, U J 2019, ' Benralizumab for the Prevention of COPD Exacerbations ', New England Journal Of Medicine, vol. 381, pp. 1023-1034 . https://doi.org/10.1056/NEJMoa1905248 New England Journal of Medicine New England Journal of Medicine, 2019, 381 (11), pp.1023-1034. ⟨10.1056/NEJMoa1905248⟩